Clinical trials
Recruiting Observational Arrhythmias, Cardiac trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
81 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 15 |
| 2024 | 14 |
| 2025 | 8 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 81 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abbott Medical Devices | 5 |
| University Hospital of Ferrara | 4 |
| Stanford University | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Mayo Clinic | 2 |
| National Cerebral and Cardiovascular Center, Japan | 2 |
| Scientific Institute San Raffaele | 2 |
| The Cleveland Clinic | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arrhythmias, Cardiac | 81 |
| Atrial Fibrillation | 25 |
| Heart Failure | 18 |
| Cardiomyopathies | 13 |
| Cardiovascular Diseases | 9 |
| Death, Sudden, Cardiac | 9 |
| Bradycardia | 7 |
| Heart Diseases | 7 |
| Stroke | 6 |
| Tachycardia, Ventricular | 6 |
Trials
Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.